Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 191

1.

Combination of CCl4with alcoholic and metabolic injuries mimics human liver fibrosis.

Brol MJ, Rösch F, Schierwagen R, Magdaleno F, Uschner FE, Manekeller S, Queck A, Schwarzkopf K, Odenthal M, Drebber U, Thiele M, Lingohr P, Plamper A, Kristiansen G, Lotersztajn S, Krag A, Klein S, Rheinwalt KP, Trebicka J.

Am J Physiol Gastrointest Liver Physiol. 2019 Jun 12. doi: 10.1152/ajpgi.00361.2018. [Epub ahead of print]

PMID:
31188634
2.

[Proton pump inhibitors in patients with liver cirrhosis - a survey among hepatologists in Germany].

Horvatits T, Drolz A, Wehmeyer M, Steib C, Trebicka J, Lohse AW, Kluwe J.

Z Gastroenterol. 2019 Jun;57(6):729-733. doi: 10.1055/a-0832-2694. Epub 2019 Jun 6. German.

PMID:
31170742
3.

Quantification of liver fibrosis: extracellular volume fraction using an MRI bolus-only technique in a rat animal model.

Luetkens JA, Klein S, Träber F, Block W, Schmeel FC, Sprinkart AM, Kuetting DLR, Uschner FE, Schierwagen R, Thomas D, Trebicka J, Kukuk GM.

Eur Radiol Exp. 2019 May 29;3(1):22. doi: 10.1186/s41747-019-0100-y.

PMID:
31144201
4.

[Updated S2k-Guideline "Complications of liver cirrhosis". German Society of Gastroenterology (DGVS)].

Gerbes AL, Labenz J, Appenrodt B, Dollinger M, Gundling F, Gülberg V, Holstege A, Lynen-Jansen P, Steib CJ, Trebicka J, Wiest R, Zipprich A; Deutsche Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV); Deutsche Gesellschaft für Innere Medizin e. V. (DGIM); Deutsche Gesellschaft für Infektiologie e. V. (DGI); Deutsche Gesellschaft für Pathologie e. V./Bundesverband deutscher Pathologen e. V. (DGP/BDP); Deutsche Röntgengesellschaft e. V. (DRG); Deutsche Gesellschaft für Interventionelle Radiologie und minimal-invasive Therapie (DeGIR); Deutsche Gesellschaft für Nephrologie (DGFN); Deutsche Gesellschaft für Ultraschall in der Medizin (DEGUM); Deutsche Gesellschaft für Neurologie e. V. (DGN); Deutsche Gesellschaft für Ernährungsmedizin e. V. (DGEM); Lebertransplantierte Deutschland e. V; Collaborators:.

Z Gastroenterol. 2019 May;57(5):e168. doi: 10.1055/a-0928-2800. Epub 2019 May 24. German. No abstract available.

PMID:
31127596
5.

[Updated S2k-Guideline "Complications of liver cirrhosis". German Society of Gastroenterology (DGVS)].

Gerbes AL, Labenz J, Appenrodt B, Dollinger M, Gundling F, Gülberg V, Holstege A, Lynen-Jansen P, Steib CJ, Trebicka J, Wiest R, Zipprich A; Deutsche Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV); Deutsche Gesellschaft für Innere Medizin e. V. (DGIM); Deutsche Gesellschaft für Infektiologie e. V. (DGI); Deutsche Gesellschaft für Pathologie e. V./Bundesverband deutscher Pathologen e. V. (DGP/BDP); Deutsche Röntgengesellschaft e. V. (DRG); Deutsche Gesellschaft für Interventionelle Radiologie und minimal-invasive Therapie (DeGIR); Deutsche Gesellschaft für Nephrologie (DGFN); Deutsche Gesellschaft für Ultraschall in der Medizin (DEGUM); Deutsche Gesellschaft für Neurologie e. V. (DGN); Deutsche Gesellschaft für Ernährungsmedizin e. V. (DGEM); Lebertransplantierte Deutschland e. V; Collaborators:.

Z Gastroenterol. 2019 May;57(5):611-680. doi: 10.1055/a-0873-4658. Epub 2019 May 6. German.

6.

Left Ventricular Longitudinal Contractility Predicts Acute-on-Chronic Liver Failure Development and Mortality After Transjugular Intrahepatic Portosystemic Shunt.

Jansen C, Schröder A, Schueler R, Lehmann J, Praktiknjo M, Uschner FE, Schierwagen R, Thomas D, Monteiro S, Nickenig G, Strassburg CP, Meyer C, Arroyo V, Hammerstingl C, Trebicka J.

Hepatol Commun. 2019 Jan 22;3(3):340-347. doi: 10.1002/hep4.1308. eCollection 2019 Mar.

7.

Porto-sinusoidal vascular disease: proposal and description of a novel entity.

De Gottardi A, Rautou PE, Schouten J, Rubbia-Brandt L, Leebeek F, Trebicka J, Murad SD, Vilgrain V, Hernandez-Gea V, Nery F, Plessier A, Berzigotti A, Bioulac-Sage P, Primignani M, Semela D, Elkrief L, Bedossa P, Valla D, Garcia-Pagan JC; VALDIG group.

Lancet Gastroenterol Hepatol. 2019 May;4(5):399-411. doi: 10.1016/S2468-1253(19)30047-0.

PMID:
30957754
8.

Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated Cirrhosis.

Trebicka J, Amoros A, Pitarch C, Titos E, Alcaraz-Quiles J, Schierwagen R, Deulofeu C, Fernandez-Gomez J, Piano S, Caraceni P, Oettl K, Sola E, Laleman W, McNaughtan J, Mookerjee RP, Coenraad MJ, Welzel T, Steib C, Garcia R, Gustot T, Rodriguez Gandia MA, Bañares R, Albillos A, Zeuzem S, Vargas V, Saliba F, Nevens F, Alessandria C, de Gottardi A, Zoller H, Ginès P, Sauerbruch T, Gerbes A, Stauber RE, Bernardi M, Angeli P, Pavesi M, Moreau R, Clària J, Jalan R, Arroyo V.

Front Immunol. 2019 Mar 19;10:476. doi: 10.3389/fimmu.2019.00476. eCollection 2019.

9.

Smaller-Diameter Covered Transjugular Intrahepatic Portosystemic Shunt Stents Are Associated With Increased Survival.

Trebicka J, Bastgen D, Byrtus J, Praktiknjo M, Terstiegen S, Meyer C, Thomas D, Fimmers R, Treitl M, Euringer W, Sauerbruch T, Rössle M.

Clin Gastroenterol Hepatol. 2019 Mar 30. pii: S1542-3565(19)30352-0. doi: 10.1016/j.cgh.2019.03.042. [Epub ahead of print]

10.

Sarcopenia Is Associated With Development of Acute-on-Chronic Liver Failure in Decompensated Liver Cirrhosis Receiving Transjugular Intrahepatic Portosystemic Shunt.

Praktiknjo M, Clees C, Pigliacelli A, Fischer S, Jansen C, Lehmann J, Pohlmann A, Lattanzi B, Krabbe VK, Strassburg CP, Arroyo V, Merli M, Meyer C, Trebicka J.

Clin Transl Gastroenterol. 2019 Apr;10(4):e00025. doi: 10.14309/ctg.0000000000000025.

PMID:
30939488
11.

Activation of the Alternate Renin-Angiotensin System Correlates with the Clinical Status in Human Cirrhosis and Corrects Post Liver Transplantation.

Casey S, Schierwagen R, Mak KY, Klein S, Uschner F, Jansen C, Praktiknjo M, Meyer C, Thomas D, Herath C, Jones R, Trebicka J, Angus P.

J Clin Med. 2019 Mar 27;8(4). pii: E419. doi: 10.3390/jcm8040419.

12.

Abdominal Surgery in Patients With Idiopathic Noncirrhotic Portal Hypertension: A Multicenter Retrospective Study.

Elkrief L, Ferrusquia-Acosta J, Payancé A, Moga L, Tellez L, Praktiknjo M, Procopet B, Farcau O, De Lédinghen V, Yuldashev R, Tabchouri N, Barbier L, Dumortier J, Menahem B, Magaz M, Hernández-Gea V, Albillos A, Trebicka J, Spahr L, De Gottardi A, Plessier A, Valla D, Rubbia-Brandt L, Toso C, Bureau C, Garcia-Pagan JC, Rautou PE; for VALDIG, an EASL consortium.

Hepatology. 2019 Mar 29. doi: 10.1002/hep.30628. [Epub ahead of print]

PMID:
30924941
13.

Editorial: diastolic dysfunction seems not to be decisive for survival after transjugular intrahepatic portosystemic stent-shunt.

Jansen C, Trebicka J.

Aliment Pharmacol Ther. 2019 Apr;49(8):1101-1102. doi: 10.1111/apt.15221. No abstract available.

PMID:
30920049
14.

Fibroblast growth factor 21 is independently associated with severe hepatic steatosis in non-obese HIV-infected patients.

Praktiknjo M, Djayadi N, Mohr R, Schierwagen R, Bischoff J, Dold L, Pohlmann A, Schwarze-Zander C, Wasmuth JC, Boesecke C, Rockstroh JK, Trebicka J.

Liver Int. 2019 Mar 27. doi: 10.1111/liv.14107. [Epub ahead of print]

PMID:
30916873
15.

Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis.

Fernández J, Clària J, Amorós A, Aguilar F, Castro M, Casulleras M, Acevedo J, Duran-Güell M, Nuñez L, Costa M, Torres M, Horrillo R, Ruiz-Del-Árbol L, Villanueva C, Prado V, Arteaga M, Trebicka J, Angeli P, Merli M, Alessandria C, Aagaard NK, Soriano G, Durand F, Gerbes A, Gustot T, Welzel TM, Salerno F, Bañares R, Vargas V, Albillos A, Silva A, Morales-Ruiz M, Pavesi M, Jalan R, Bernardi M, Moreau R, Páez A, Arroyo V.

Gastroenterology. 2019 Mar 22. pii: S0016-5085(19)33576-0. doi: 10.1053/j.gastro.2019.03.021. [Epub ahead of print]

16.

AngioJet-assisted transvenous-transhepatic mechanical thrombectomy in the portal vein.

Kuetting D, Wolter K, Luetkens J, Trebicka J, Praktiknjo M, Thomas D, Meyer C.

Pol J Radiol. 2018 Dec 28;83:e536-e544. doi: 10.5114/pjr.2018.81380. eCollection 2018.

17.

Compartmentalization of Immune Response and Microbial Translocation in Decompensated Cirrhosis.

Alvarez-Silva C, Schierwagen R, Pohlmann A, Magdaleno F, Uschner FE, Ryan P, Vehreschild MJGT, Claria J, Latz E, Lelouvier B, Arumugam M, Trebicka J.

Front Immunol. 2019 Feb 8;10:69. doi: 10.3389/fimmu.2019.00069. eCollection 2019.

18.

Rho-kinase inhibitor coupled to peptide-modified albumin carrier reduces portal pressure and increases renal perfusion in cirrhotic rats.

Klein S, Frohn F, Magdaleno F, Reker-Smit C, Schierwagen R, Schierwagen I, Uschner FE, van Dijk F, Fürst DO, Djudjaj S, Boor P, Poelstra K, Beljaars L, Trebicka J.

Sci Rep. 2019 Feb 19;9(1):2256. doi: 10.1038/s41598-019-38678-5.

19.

Collagen type IV remodelling gender-specifically predicts mortality in decompensated cirrhosis.

Lehmann J, Praktiknjo M, Nielsen MJ, Schierwagen R, Meyer C, Thomas D, Violi F, Strassburg CP, Bendtsen F, Møller S, Krag A, Karsdal MA, Leeming DJ, Trebicka J.

Liver Int. 2019 May;39(5):885-893. doi: 10.1111/liv.14070. Epub 2019 Mar 7.

PMID:
30739387
20.

Fat-free muscle area measured by magnetic resonance imaging predicts overall survival of patients undergoing radioembolization of colorectal cancer liver metastases.

Faron A, Pieper CC, Schmeel FC, Sprinkart AM, Kuetting DLR, Fimmers R, Trebicka J, Schild HH, Meyer C, Thomas D, Luetkens JA.

Eur Radiol. 2019 Jan 28. doi: 10.1007/s00330-018-5976-z. [Epub ahead of print]

PMID:
30689036
21.

Liver stiffness regression after successful Hepatitis C treatment is independent of HIV coinfection.

Malin JJ, Boesecke C, Schwarze-Zander C, Wasmuth JC, Schlabe S, Trebicka J, Spengler U, Llibre JM, Jou T, Vasylyev M, Clotet B, Rockstroh JK.

HIV Med. 2019 Mar;20(3):230-236. doi: 10.1111/hiv.12705. Epub 2019 Jan 27.

PMID:
30687989
22.

Combined photodynamic therapy with systemic chemotherapy for unresectable cholangiocarcinoma.

Gonzalez-Carmona MA, Bolch M, Jansen C, Vogt A, Sampels M, Mohr RU, van Beekum K, Mahn R, Praktiknjo M, Nattermann J, Trebicka J, Branchi V, Matthaei H, Manekeller S, Kalff JC, Strassburg CP, Weismüller TJ.

Aliment Pharmacol Ther. 2019 Feb;49(4):437-447. doi: 10.1111/apt.15050. Epub 2019 Jan 13.

PMID:
30637783
23.

The multikinase inhibitor regorafenib decreases angiogenesis and improves portal hypertension.

Uschner FE, Schueller F, Nikolova I, Klein S, Schierwagen R, Magdaleno F, Gröschl S, Loosen S, Ritz T, Roderburg C, Vucur M, Kristiansen G, Lammers T, Luedde T, Trebicka J.

Oncotarget. 2018 Nov 16;9(90):36220-36237. doi: 10.18632/oncotarget.26333. eCollection 2018 Nov 16.

24.

Orchestration of Tryptophan-Kynurenine Pathway, Acute Decompensation, and Acute-on-Chronic Liver Failure in Cirrhosis.

Clària J, Moreau R, Fenaille F, Amorós A, Junot C, Gronbaek H, Coenraad MJ, Pruvost A, Ghettas A, Chu-Van E, López-Vicario C, Oettl K, Caraceni P, Alessandria C, Trebicka J, Pavesi M, Deulofeu C, Albillos A, Gustot T, Welzel TM, Fernández J, Stauber RE, Saliba F, Butin N, Colsch B, Moreno C, Durand F, Nevens F, Bañares R, Benten D, Ginès P, Gerbes A, Jalan R, Angeli P, Bernardi M, Arroyo V; CANONIC Study Investigators of the EASL Clif Consortium, Grifols Chair and the European Foundation for the Study of Chronic Liver Failure (EF Clif).

Hepatology. 2019 Apr;69(4):1686-1701. doi: 10.1002/hep.30363. Epub 2019 Mar 19.

PMID:
30521097
25.

Perforin inhibition protects from lethal endothelial damage during fulminant viral hepatitis.

Welz M, Eickhoff S, Abdullah Z, Trebicka J, Gartlan KH, Spicer JA, Demetris AJ, Akhlaghi H, Anton M, Manske K, Zehn D, Nieswandt B, Kurts C, Trapani JA, Knolle P, Wohlleber D, Kastenmüller W.

Nat Commun. 2018 Nov 15;9(1):4805. doi: 10.1038/s41467-018-07213-x.

26.

Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe.

Fernández J, Prado V, Trebicka J, Amoros A, Gustot T, Wiest R, Deulofeu C, Garcia E, Acevedo J, Fuhrmann V, Durand F, Sánchez C, Papp M, Caraceni P, Vargas V, Bañares R, Piano S, Janicko M, Albillos A, Alessandria C, Soriano G, Welzel TM, Laleman W, Gerbes A, De Gottardi A, Merli M, Coenraad M, Saliba F, Pavesi M, Jalan R, Ginès P, Angeli P, Arroyo V; European Foundation for the Study of Chronic Liver Failure (EF-Clif).

J Hepatol. 2019 Mar;70(3):398-411. doi: 10.1016/j.jhep.2018.10.027. Epub 2018 Nov 2.

PMID:
30391380
27.

Acute-on-Chronic Liver Failure.

Lange CM, Bechstein WO, Berg T, Engelmann C, Bruns T, Canbay A, Moreau R, Trebicka J.

Visc Med. 2018 Aug;34(4):296-300. doi: 10.1159/000491406. Epub 2018 Jul 12. Review. No abstract available.

28.

Gut-Liver Axis Links Portal Hypertension to Acute-on-Chronic Liver Failure.

Trebicka J, Reiberger T, Laleman W.

Visc Med. 2018 Aug;34(4):270-275. doi: 10.1159/000490262. Epub 2018 Jul 13. Review.

29.

Prioritization of Therapeutic Targets and Trial Design in Cirrhotic Portal Hypertension.

Abraldes JG, Trebicka J, Chalasani N, D'Amico G, Rockey DC, Shah VH, Bosch J, Garcia-Tsao G.

Hepatology. 2019 Mar;69(3):1287-1299. doi: 10.1002/hep.30314. Epub 2019 Feb 9.

PMID:
30318607
30.

Systemic Inflammation and Acute-on-Chronic Liver Failure: Too Much, Not Enough.

Laleman W, Claria J, Van der Merwe S, Moreau R, Trebicka J.

Can J Gastroenterol Hepatol. 2018 Aug 1;2018:1027152. doi: 10.1155/2018/1027152. eCollection 2018. Review.

31.

Statins: Old drugs as new therapy for liver diseases?

Pose E, Trebicka J, Mookerjee RP, Angeli P, Ginès P.

J Hepatol. 2019 Jan;70(1):194-202. doi: 10.1016/j.jhep.2018.07.019. Epub 2018 Aug 1. Review.

32.

Interventional Treatment of Acute Portal Vein Thrombosis.

Wolter K, Decker G, Kuetting D, Trebicka J, Manekeller S, Meyer C, Schild H, Thomas D.

Rofo. 2018 Aug;190(8):740-746. doi: 10.1055/a-0631-9265. Epub 2018 Jul 25.

33.

Preemptive-TIPS Improves Outcome in High-Risk Variceal Bleeding: An Observational Study.

Hernández-Gea V, Procopet B, Giráldez Á, Amitrano L, Villanueva C, Thabut D, Ibañez-Samaniego L, Silva-Junior G, Martinez J, Genescà J, Bureau C, Trebicka J, Llop E, Laleman W, Palazon JM, Castellote J, Rodrigues S, Gluud LL, Noronha Ferreira C, Barcelo R, Cañete N, Rodríguez M, Ferlitsch A, Mundi JL, Gronbaek H, Hernández-Guerra M, Sassatelli R, Dell'Era A, Senzolo M, Abraldes JG, Romero-Gómez M, Zipprich A, Casas M, Masnou H, Primignani M, Krag A, Nevens F, Calleja JL, Jansen C, Robic MA, Conejo I, Catalina MV, Albillos A, Rudler M, Alvarado E, Guardascione MA, Tantau M, Bosch J, Torres F, Garcia-Pagán JC; International Variceal Bleeding Observational Study Group and Baveno Cooperation.

Hepatology. 2019 Jan;69(1):282-293. doi: 10.1002/hep.30182. Epub 2018 Dec 10.

34.

Closed-Loop Lumped Parameter Modeling of Hemodynamics During Cirrhogenesis in Rats.

Audebert C, Peeters G, Segers P, Laleman W, Monbaliu D, Korf H, Trebicka J, Vignon-Clementel IE, Debbaut C.

IEEE Trans Biomed Eng. 2018 Oct;65(10):2311-2322. doi: 10.1109/TBME.2018.2793948. Epub 2018 Jan 15.

PMID:
29993530
35.

Quantification of Liver Fibrosis at T1 and T2 Mapping with Extracellular Volume Fraction MRI: Preclinical Results.

Luetkens JA, Klein S, Träber F, Schmeel FC, Sprinkart AM, Kuetting DLR, Block W, Uschner FE, Schierwagen R, Hittatiya K, Kristiansen G, Gieseke J, Schild HH, Trebicka J, Kukuk GM.

Radiology. 2018 Sep;288(3):748-754. doi: 10.1148/radiol.2018180051. Epub 2018 Jun 26.

PMID:
29944086
36.

Non-cirrhotic portal hypertension: A possibly benign but complicated disease.

Trebicka J.

Dig Liver Dis. 2018 Aug;50(8):845-846. doi: 10.1016/j.dld.2018.05.018. Epub 2018 Jun 4. No abstract available.

PMID:
29935993
37.

The soluble guanylate cyclase stimulator riociguat reduces fibrogenesis and portal pressure in cirrhotic rats.

Schwabl P, Brusilovskaya K, Supper P, Bauer D, Königshofer P, Riedl F, Hayden H, Fuchs CD, Stift J, Oberhuber G, Aschauer S, Bonderman D, Gnad T, Pfeifer A, Uschner FE, Trebicka J, Rohr-Udilova N, Podesser BK, Peck-Radosavljevic M, Trauner M, Reiberger T.

Sci Rep. 2018 Jun 19;8(1):9372. doi: 10.1038/s41598-018-27656-y.

38.

[Gastrointestinal Bleeding: Update].

Trebicka J, Götz M.

Dtsch Med Wochenschr. 2018 Apr;143(7):e1. doi: 10.1055/a-0631-7339. Epub 2018 May 25. German. No abstract available.

PMID:
29801177
39.

Managing portal hypertension in patients with liver cirrhosis.

Sauerbruch T, Schierwagen R, Trebicka J.

F1000Res. 2018 May 2;7. pii: F1000 Faculty Rev-533. doi: 10.12688/f1000research.13943.1. eCollection 2018. Review.

40.

Return-to-health effect of modern combined antiretroviral therapy potentially predisposes HIV patients to hepatic steatosis.

Mohr R, Boesecke C, Dold L, Schierwagen R, Schwarze-Zander C, Wasmuth JC, Weisensee I, Rockstroh JK, Trebicka J.

Medicine (Baltimore). 2018 Apr;97(17):e0462. doi: 10.1097/MD.0000000000010462.

41.

Severe abnormal Heart Rate Turbulence Onset is associated with deterioration of liver cirrhosis.

Jansen C, Al-Kassou B, Lehmann J, Pohlmann A, Chang J, Praktiknjo M, Nickenig G, Strassburg CP, Schrickel JW, Andrié R, Linhart M, Trebicka J.

PLoS One. 2018 Apr 10;13(4):e0195631. doi: 10.1371/journal.pone.0195631. eCollection 2018.

42.

[Gastrointestinal Bleeding: Update].

Trebicka J, Götz M.

Dtsch Med Wochenschr. 2018 Apr;143(7):503-508. doi: 10.1055/s-0043-114049. Epub 2018 Apr 3. German. Erratum in: Dtsch Med Wochenschr. 2018 Apr;143(7):e1.

PMID:
29614542
43.

Circulating microbiome in blood of different circulatory compartments.

Schierwagen R, Alvarez-Silva C, Madsen MSA, Kolbe CC, Meyer C, Thomas D, Uschner FE, Magdaleno F, Jansen C, Pohlmann A, Praktiknjo M, Hischebeth GT, Molitor E, Latz E, Lelouvier B, Trebicka J, Arumugam M.

Gut. 2018 Mar 26. pii: gutjnl-2018-316227. doi: 10.1136/gutjnl-2018-316227. [Epub ahead of print] No abstract available.

PMID:
29581241
44.

Antifibrotic and molecular aspects of rifaximin in alcoholic liver disease: study protocol for a randomized controlled trial.

Madsen BS, Trebicka J, Thiele M, Israelsen M, Arumugan M, Havelund T, Krag A.

Trials. 2018 Feb 26;19(1):143. doi: 10.1186/s13063-018-2523-9.

45.

Fibroblast growth factor 21 is an early predictor of acute-on-chronic liver failure in critically ill patients with cirrhosis.

Ruiz-Margáin A, Pohlmann A, Ryan P, Schierwagen R, Chi-Cervera LA, Jansen C, Mendez-Guerrero O, Flores-García NC, Lehmann J, Torre A, Macías-Rodríguez RU, Trebicka J.

Liver Transpl. 2018 May;24(5):595-605. doi: 10.1002/lt.25041. Epub 2018 Apr 6.

46.

Does Transjugular Intrahepatic Portosystemic Shunt Stent Differentially Improve Survival in a Subset of Cirrhotic Patients?

Trebicka J.

Semin Liver Dis. 2018 Feb;38(1):87-96. doi: 10.1055/s-0038-1627457. Epub 2018 Feb 22. Review.

PMID:
29471569
47.

Evolution of nodule stiffness might predict response to local ablative therapy: A series of patients with hepatocellular carcinoma.

Praktiknjo M, Krabbe V, Pohlmann A, Sampels M, Jansen C, Meyer C, Strassburg CP, Trebicka J, Gonzalez Carmona MA.

PLoS One. 2018 Feb 14;13(2):e0192897. doi: 10.1371/journal.pone.0192897. eCollection 2018.

48.

Acute decompensation boosts hepatic collagen type III deposition and deteriorates experimental and human cirrhosis.

Praktiknjo M, Lehmann J, Nielsen MJ, Schierwagen R, Uschner FE, Meyer C, Thomas D, Strassburg CP, Bendtsen F, Møller S, Krag A, Karsdal MA, Leeming DJ, Trebicka J.

Hepatol Commun. 2018 Jan 18;2(2):211-222. doi: 10.1002/hep4.1135. eCollection 2018 Feb.

49.

microRNA-200a: A stage-dependent biomarker and predictor of steatosis and liver cell injury in human immunodeficiency virus patients.

Austermann C, Schierwagen R, Mohr R, Anadol E, Klein S, Pohlmann A, Jansen C, Strassburg CP, Schwarze-Zander C, Boesecke C, Rockstroh JK, Odenthal M, Trebicka J.

Hepatol Commun. 2017 Feb 27;1(1):36-45. doi: 10.1002/hep4.1017. eCollection 2017 Feb.

50.

Association Between Grade of Acute on Chronic Liver Failure and Response to Terlipressin and Albumin in Patients With Hepatorenal Syndrome.

Piano S, Schmidt HH, Ariza X, Amoros A, Romano A, Hüsing-Kabar A, Solà E, Gerbes A, Bernardi M, Alessandria C, Scheiner B, Tonon M, Maschmeier M, Solè C, Trebicka J, Gustot T, Nevens F, Arroyo V, Gines P, Angeli P; EASL CLIF Consortium, European Foundation for the Study of Chronic Liver Failure (EF Clif).

Clin Gastroenterol Hepatol. 2018 Nov;16(11):1792-1800.e3. doi: 10.1016/j.cgh.2018.01.035. Epub 2018 Jan 31.

PMID:
29391267

Supplemental Content

Loading ...
Support Center